Healthpeak Properties Demonstrates Strong Post-Merger Integration

The strategic merger between Physicians Realty Trust and Healthpeak Properties has fundamentally reshaped the healthcare real estate landscape. The newly combined entity is demonstrating robust operational and financial performance as it capitalizes on the dynamic market environment.

Financial Performance and Market Position

Healthpeak Properties, the leading healthcare REIT formed through an all-stock transaction finalized on March 4, 2024, is already exceeding initial synergy projections. The company’s second-quarter 2025 results reveal significant operational strength:

• Adjusted FFO: $0.46 per share
• AFFO: $0.44 per share
• Same-Store NOI Growth: 3.5% across the combined portfolio
• Net Debt to EBITDAre: 5.2x (as of June 30, 2025)

The company’s available liquidity remains strong at $2.3 billion as of July 24, 2025.

Exceeding Synergy Targets and Strategic Execution

A core rationale for the merger was achieving scale, operational synergies, and a more resilient portfolio structure. Healthpeak has surpassed its original 2024 synergy forecast of $40 million. The firm is now targeting an additional $20 million or more by the end of 2025. The internalization of property management across several markets is advancing more rapidly than initially anticipated.

The integration of Physicians Realty Trust is yielding measurable success; Healthpeak exceeded its first-year synergy goal by over 25% and now anticipates total synergies to surpass $65 million. Furthermore, the proportion of staff dedicated to direct operational support has increased from under 50% to 70% within a two-year period.

Operational Highlights by Segment

During Q2 2025, Healthpeak executed 1.5 million square feet of new and renewed leases. Segment performance varied, highlighting the diversity of the portfolio:

Should investors sell immediately? Or is it worth buying Physicians Realty?

• Outpatient Medical Buildings: This segment led with 1 million square feet of new and renewed leases, an 85% retention rate, and cash-releasing spreads of 6%.
• Life Science: Activity included 503,000 square feet with an 87% retention rate and spreads of 6%. The segment had previously shown impressive same-store NOI growth of 7.7% in Q1 2025.
• Senior Housing: The ongoing recovery in this sector continued, evidenced by a 17.4% NOI growth in Q1 2025.

The overall portfolio occupancy rate did decline by 150 basis points in Q2 2025, primarily due to natural lease expirations.

Disciplined Capital Management

Healthpeak is actively managing its balance sheet with strategic discipline. In June 2025, the company repaid $450 million in Senior Notes using proceeds from its commercial paper program. Management is opportunistically evaluating further refinancing activities through the debt market.

The company is also pursuing growth through development, underscored by two new projects in the Atlanta market with total costs of $148 million. Concurrently, Healthpeak is optimizing its asset base, having completed sales of land and buildings that generated approximately $35 million in proceeds.

Market Reception and Analyst Outlook

The market has sent mixed signals regarding Healthpeak’s equity. Although shares gained 0.45% to close at $17.94 last Friday, a recent price dip accompanied by higher trading volume suggests some near-term bearish sentiment.

Despite this short-term volatility, analysts maintain a “Buy” rating on the stock, with a consensus price target of $19.35 for 2025, reflecting confidence in the company’s long-term strategy and the successful integration.